Sterile compounding 503B facility quva pharma, INC.:1327585
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N90019D00030
- Awardee
-
Quva Pharma, Inc. UEI MUABDCZXMLG4
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Task orders
- 5 $574,199 obligated
Award facts
- Opportunity
-
- 503A and 503B Outsourcing Facility to Supply TPN and other Sterile Compounded Products Solicitation · NIHCC19011876 · Posted Jul 8, 2019
- Combined order value
- $574,199 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 38% used
- $1,500,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This summary covers a multiple award Indefinite Delivery Contract (IDC) awarded by the Department of Health and Human Services' National Institutes of Health (NIH) Clinical Center to Quva Pharma, Inc., a 503B outsourcing facility. The $1.5 million IDC, awarded in September 2019, enables the NIH Clinical Center to issue firm fixed price delivery orders for Quva Pharma's sterile compounding services through September 2024. Under this contract, Quva Pharma has been tasked with providing specialized sterile pharmaceutical products and patient-controlled analgesia services to support the Clinical Center's high-quality inpatient clinical research initiatives. Past task orders have included $174,000 for unspecified products/services, $100,000 for outsourcing patient-controlled analgesia systems and epidurals, and $11,517.36 for additional unspecified pharmaceutical items. This IDC allows the NIH Clinical Center, as the intramural research hospital of the NIH, to leverage Quva Pharma's expertise as an experienced 503B vendor to obtain crucial sterile pharmaceutical preparations in support of the NIH's mission to turn discovery into health through clinical research. The original solicitation was a streamlined commercial items procurement under simplified acquisition procedures, with the associated NAICS code of 325412 for Pharmaceutical Preparation Manufacturing.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Outsourcing pcas and epidurals | NIH Clinical Center | $250,000 | |
| Outsourcing pcas and epidurals | NIH Clinical Center | $100,000 | |
| Quva pharma, INC.:1327585 [pots: 20-011327] | NIH Clinical Center | $174,000 | |
| Quva pharma, INC.:1327585 [pots: 20-001401] | NIH Clinical Center | $45,670 | |
| Quva pharma, INC.:1327585 [19-017387] | NIH Clinical Center | $4,529 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N90019D00030?
75N90019D00030 was awarded to Quva Pharma, Inc. by NIH Clinical Center (National Institutes of Health) on September 27, 2019.
How much is contract 75N90019D00030 worth?
Orders under 75N90019D00030 have obligated $574,199. 75N90019D00030's own ceiling is $1,500,000.
How many orders have been placed under contract 75N90019D00030?
5 orders have been placed under 75N90019D00030, the latest on April 22, 2024.
Who can order from contract 75N90019D00030?
75N90019D00030 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N90019D00030 competed?
The extent of competition for 75N90019D00030 was competed under sap. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV